A public oncology unit in Manzini, Eswatini, established in 2022 with a 60-bed ward and an outpatient clinic, where chemotherapy is given. The Ministry of Health has identified the same hospital as the site for the country's first radiotherapy unit.
The Ministry of Health's National Cancer Control Strategic Plan 2025 to 2029 says cancer treatment capacity grew with the establishment of the Manzini Oncology Unit in 2022, and lists a 60-bed oncology ward and outpatient clinic at Manzini, with chemotherapy also available at Mbabane Hospital. A Ministry presentation of 17 July 2024 lists "Manzini Hospital- Oncology Unit" as a 2022 milestone, and Applied Radiation Oncology's report of 2 January 2025 on the IAEA-led review of August 2024 describes a 60-bed chemotherapy unit operating at Manzini Government Hospital.
The plan says the site for the country's first radiotherapy unit has been identified at Manzini Hospital, with 1 million US dollars allocated in the 2024 budget for initial works, and recommends a roadmap for children's cancer services there. The cervical cancer elimination acceleration plan describes the planned national radiotherapy centre as having two linear accelerators and one brachytherapy unit. Neither document gives an opening date. The cervical cancer elimination plan says there is no radiotherapy capacity in Eswatini, and Applied Radiation Oncology's report says no radiotherapy services were available within the country. The coordinates are an approximate city point for Manzini.
The registry now holds enough years of data to show where the losses are: late diagnosis and no treatment. Both are things screening, referral and a radiotherapy service inside the country are meant to change.
The trend in stage at diagnosis is moving the right way, and the authors say attention is warranted to reduce diagnoses of metastatic cancer in women living with HIV.
It is the ministry's own account of the launch, and the baseline against which later coverage figures can be read.
Radiotherapy, which is not available in Eswatini, is the largest cost per patient, and travel and lodging are a cost in their own right.
More than half of the total, $10.4 million of $19 million, is the cost of treating stage III and stage IV disease, and less than 1% of direct costs goes on treating pre-cancer. The authors conclude that HPV vaccination and screening should be prioritised.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/